PROGRESS-GT LOPD Trademark
Trademark Overview
On Friday, October 10, 2025, a trademark application was filed for PROGRESS-GT LOPD with the United States Patent and Trademark Office. The USPTO has given the PROGRESS-GT LOPD trademark a serial number of 99436468. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Wednesday, March 11, 2026. This trademark is owned by AskBio Inc.. The PROGRESS-GT LOPD trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:
Clinical research services in the field of gene therapy, namely, the recruitment of patients for clinical trials; Patient recruitment for clinical trials
Providing medical and scientific research information; Providing medical and scientific research information about gene therapy and clinical trials
General Information
| Serial Number | 99436468 |
| Word Mark | PROGRESS-GT LOPD |
| Filing Date | Friday, October 10, 2025 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Wednesday, March 11, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| NOT AVAILABLE | "LOPD" |
| Pseudo Mark | PROGRESS GT LATE ONSET POMPE DISEASE |
| Description of Mark | The mark consists of the wording PROGRESS-GT, in stylized, upper-case letters, and LOPD in larger, bold, stylized, upper-case-letters, appearing on two lines, to the left of a double helix design. |
| Goods and Services | Clinical research services in the field of gene therapy, namely, the recruitment of patients for clinical trials; Patient recruitment for clinical trials |
| Goods and Services | Providing medical and scientific research information; Providing medical and scientific research information about gene therapy and clinical trials |
Classification Information
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, March 11, 2026 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, October 10, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | AskBio Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Durham, NC 27713
US |
Trademark Events
| Event Date | Event Description |
| Friday, October 10, 2025 | NEW APPLICATION ENTERED |
| Friday, October 10, 2025 | APPLICATION FILING RECEIPT MAILED |
| Thursday, February 26, 2026 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, February 26, 2026 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Friday, February 27, 2026 | ASSIGNED TO EXAMINER |
| Saturday, February 28, 2026 | NON-FINAL ACTION WRITTEN |
| Saturday, February 28, 2026 | NON-FINAL ACTION E-MAILED |
| Saturday, February 28, 2026 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, March 11, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, March 11, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, March 11, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
